Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager

(NASDAQ:ZYME) VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifu...

Symbol: ZYME
14 days ago

High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

(NASDAQ:HITI) CALGARY, AB, Sept. 2, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to de...

Symbol: HITI
14 days ago